Skip to Main Content

Paper Details

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections.
JAMA Netw Open
9
2023
COVID-19, Molnupiravir, Nirmatrelvir, Omicron, Omicron Infections, Omicron infection, Ritonavir, SARS, SARS-CoV-2, XBB, molnupiravir, nirmatrelvir, patients, ritonavir
Author NameAffiliation
Dan-Yu LinUniversity of North Carolina
Abhijit DuggalCleveland Clinic
  • 1 - 2

Datasets

Release 1.2